List of Excipients in API epoprostenol

✉ Email this page to a colleague

Excipients in NDA-approved (novel) drugs containing epoprostenol

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Actelion Pharmaceuticals US Inc	VELETRI	epoprostenol	66215-403	ARGININE
Actelion Pharmaceuticals US Inc	VELETRI	epoprostenol	66215-403	SODIUM HYDROXIDE
Actelion Pharmaceuticals US Inc	VELETRI	epoprostenol	66215-403	SUCROSE
GlaxoSmithKline LLC	FLOLAN	epoprostenol sodium	0173-0517	GLYCINE
GlaxoSmithKline LLC	FLOLAN	epoprostenol sodium	0173-0517	MANNITOL
GlaxoSmithKline LLC	FLOLAN	epoprostenol sodium	0173-0517	SODIUM CHLORIDE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing epoprostenol

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059	GLYCINE
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059	SODIUM HYDROXIDE
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059	SUCROSE
Mylan Institutional LLC	epoprostenol	67457-587	ARGININE
Mylan Institutional LLC	epoprostenol	67457-587	SODIUM HYDROXIDE
Mylan Institutional LLC	epoprostenol	67457-587	SUCROSE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for epoprostenol

Excipient focus: ARGININE

epoprostenol drug variants containing ARGININE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Actelion Pharmaceuticals US Inc	epoprostenol	66215-403
Mylan Institutional LLC	epoprostenol	67457-587
>Company	>Ingredient	>NDC

epoprostenol drug variants not containing ARGININE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

Excipient focus: GLYCINE

epoprostenol drug variants containing GLYCINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

epoprostenol drug variants not containing GLYCINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Actelion Pharmaceuticals US Inc	epoprostenol	66215-403
Mylan Institutional LLC	epoprostenol	67457-587
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

epoprostenol drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

epoprostenol drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059
Actelion Pharmaceuticals US Inc	epoprostenol	66215-403
Mylan Institutional LLC	epoprostenol	67457-587
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

epoprostenol drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

epoprostenol drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059
Actelion Pharmaceuticals US Inc	epoprostenol	66215-403
Mylan Institutional LLC	epoprostenol	67457-587
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

epoprostenol drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059
Actelion Pharmaceuticals US Inc	epoprostenol	66215-403
Mylan Institutional LLC	epoprostenol	67457-587
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

epoprostenol drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
>Company	>Ingredient	>NDC

Excipient focus: SUCROSE

epoprostenol drug variants containing SUCROSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sun Pharmaceutical Industries Inc	epoprostenol	62756-059
Actelion Pharmaceuticals US Inc	epoprostenol	66215-403
Mylan Institutional LLC	epoprostenol	67457-587
>Company	>Ingredient	>NDC

epoprostenol drug variants not containing SUCROSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
GlaxoSmithKline LLC	epoprostenol sodium	0173-0517
Teva Parenteral Medicines Inc	epoprostenol sodium	0703-1985
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.